Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TGFBR1 | P36897 | 5/20 | 0.51 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.51 |
| ▸ | THRB | P10828 | 1/20 | 0.50 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.45 |
| ▸ | SQOR | Q9Y6N5 | 3/20 | 0.43 |
| ▸ | DCTPP1 | Q9H773 | 1/20 | 0.42 |
| ▸ | TOP1 | P11387 | 2/20 | 0.40 |
| ▸ | CDK1 | P06493 | 1/20 | 0.40 |
| ▸ | CDK4 | P11802 | 1/20 | 0.40 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.40 |
| ▸ | CCNA2 | P20248 | 1/20 | 0.40 |
| ▸ | CCND1 | P24385 | 1/20 | 0.40 |
| ▸ | CDK2 | P24941 | 1/20 | 0.40 |
| ▸ | CDK7 | P50613 | 1/20 | 0.40 |
| ▸ | CCNH | P51946 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | CCR1 | P32246 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL787679 | 0.87 | TGFBR1 (0.46) | TGFBR1MCL1CDK7LMNAKDM4E | |
| Dipyridyl SCHEMBL7511159 | 0.85 | KDM4E (0.48) | TGFBR1MCL1CDK7LMNAKDM4E | |
| Hydrochloric Acid SCHEMBL2455950 | 0.85 | TGFBR1 (0.45) | TGFBR1MCL1CDK7LMNAKDM4E | |
| SCHEMBL32689469 | 0.85 | TGFBR1 (0.45) | TGFBR1MCL1CDK7LMNAKDM4E | |
| Dipyridyl SCHEMBL4595525 | 0.85 | KDM4E (0.48) | TGFBR1MCL1CDK7LMNAKDM4E | |
| Hydrochloric Acid SCHEMBL1572132 | 0.85 | TGFBR1 (0.45) | TGFBR1MCL1CDK7LMNAKDM4E | |
| SCHEMBL31058350 | 0.84 | ULK1 (0.42) | TGFBR1THRBCDK7LMNAKDM4E | |
| SCHEMBL29942138 | 0.82 | TGFBR1 (0.47) | TGFBR1MCL1CDK7LMNAKDM4E | |
| SCHEMBL923478 | 0.82 | TGFBR1 (0.47) | TGFBR1MCL1CDK7LMNAKDM4E | |
| SCHEMBL2455952 | 0.81 | TGFBR1 (0.42) | TGFBR1MAPK14MCL1CDK7LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1554361-B1 | METALLIC COMPLEXES COVALENTLY BOUND TO CONJUGATED POLYMERS AND ELECTRONIC DEVICES CONTAINING SUCH COMPOSITIONS | DU PONT (US) | 2010-03-17 | — | — | EP | disclosed |
| US-7575816-B2 | Luminescent lanthanide complexes with imine ligands and devices made with such complexes | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2009-08-18 | — | — | US | disclosed |
| US-7090929-B2 | Metallic complexes covalently bound to conjugated polymers and electronic devices containing such compositions | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2006-08-15 | — | — | US | disclosed |
| US-20050233233-A1 | Luminescent lanthanide complexes with imine ligands and devices made with such complexes | RADU NORA S | 2005-10-20 | — | — | US | disclosed |
| US-20050233232-A1 | Luminescent lanthanide complexes with imine ligands and devices made with such complexes | LG CHEM, LTD. (KR) | 2005-10-20 | — | — | US | disclosed |
| US-6924047-B2 | Luminescent lanthanide complexes with imine ligands and devices made with such complexes | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2005-08-02 | — | — | US | disclosed |
| EP-1554361-A1 | METALLIC COMPLEXES COVALENTLY BOUND TO CONJUGATED POLYMERS AND ELECTRONIC DEVICES CONTAINING SUCH COMPOSITIONS | E. I. du Pont de Nemours and Company (US) | 2005-07-20 | — | — | EP | disclosed |
| US-20040072018-A1 | Metallic complexes covalently bound to conjugated polymers and electronic devices containing such compositions | LG CHEM, LTD. (KR) | 2004-04-15 | — | — | US | disclosed |
| WO-2004015025-A1 | METALLIC COMPLEXES COVALENTLY BOUND TO CONJUGATED POLYMERS AND ELECTRONIC DEVICES CONTAINING SUCH COMPOSITIONS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2004-02-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050233233-A1 | Luminescent lanthanide complexes with imine ligands and devices made with such complexes | SSB, LARP7, LIG3 | TGFBR1 4074/4885MAPK14 4190/4885THRB 4245/4885 |
| US-20050233232-A1 | Luminescent lanthanide complexes with imine ligands and devices made with such complexes | SSB, LARP7, LIG3 | TGFBR1 4074/4885MAPK14 4190/4885THRB 4245/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.